Unable to secure a profit in immunizing poorer nations, Western multinationals, including Oxford's private partner AstraZeneca, have prioritized those who can pay the most.
The post Poor Nations Left Reeling After Bill Gates Advised Oxford to Ditch Open Source COVID Vaccine appeared first on MintPress News.
Source